You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SNDX Exercise Disclosure
Metzger Michael A · SEC Form 4 · Filed Jul 9, 2026
Exercise
Calculated transaction value
$0
Metzger Michael A Chief Executive Officer
SNDX
Transaction date
Jul 8, 2026
Public filing date
Jul 9, 2026
Filing lag
Filed 1 day later
SNDX daily price context
Close on/before transaction
$24.56
Jul 8, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to buy) on Common Stock
- Quantity / price
- 32,375 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-299803
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$991.33K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Syndax Pharmaceuticals Inc SNDX | Exercise | Jul 8, 2026 | $206.55K |
| Syndax Pharmaceuticals Inc SNDX | Sale | Jul 8, 2026 | $784.78K |
| Syndax Pharmaceuticals Inc SNDX Current | Exercise | Jul 8, 2026 | $0 |